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ABSTRACT: We have investigated the applicability of
commercially available lyophilized spirulina (Arthrospira
platensis), a microorganism uniformly labeled with 13C, as a
readily accessible source of multiple 13C-labeled metabolites
suitable as internal standards for the quantitative determination
of intracellular bacterial metabolites. Metabolites of interest
were analyzed by hydrophilic-interaction liquid chromatography
coupled with high-resolution mass spectrometry. Multiple
internal standards obtained from uniformly (U)-13C-labeled
extracts from spirulina were used to enable isotope-dilution
mass spectrometry (IDMS) in the identiﬁcation and quantiﬁ-
cation of intracellular metabolites. Extraction of the intracellular
metabolites of Clostridium autoethanogenum using 2:1:1 chloro-
form/methanol/water was found to be the optimal method in comparison with freeze−thaw, homogenization, and sonication
methods. The limits of quantiﬁcation were ≤1 μM with excellent linearity for all of the calibration curves (R2 ≥ 0.99) for 74
metabolites. The precision and accuracy were found to be within relative standard deviations (RSDs) of 15% for 49 of the
metabolites and within RSDs of 20% for all of the metabolites. The method was applied to study the eﬀects of feeding diﬀerent
levels of carbon monoxide (as a carbon source) on the central metabolism and Wood−Ljungdahl pathway of C. autoethanogenum
grown in continuous culture over 35 days. Using LC-IDMS with U-13C spirulina allowed the successful quantiﬁcation of 52
metabolites in the samples, including amino acids, carboxylic acids, sugar phosphates, purines, and pyrimidines. The method
provided absolute quantitative data on intracellular metabolites that was suitable for computational modeling to understand and
optimize the C. autoethanogenum metabolic pathways active in gas fermentation.
Q uantitative biology aims to explain the function of anentire biological system, and intracellular-metabolite
analysis is an important aspect of this approach because it
reveals functional information about the biochemical and
physiological states of cells.1,2 Metabolomics can provide
“global” information on metabolites, but frequently this is not
quantitative in nature (for example, by not providing precise
concentrations) and is thus diﬃcult to apply in accurate
modelings of intracellular processes required in systems biology
and metabolic engineering. LC-MS methods have previously
been reported for the simultaneous quantiﬁcation of diﬀerent
classes of intracellular metabolites in microorganisms using
mainly hydrophilic interaction liquid chromatography
(HILIC)3,4 and ion-pair reversed-phase chromatography.5,6
Although such LC-MS methods produce comprehensive data,
there are signiﬁcant limitations in achieving the absolute
quantiﬁcation of multiple metabolites, with ion enhancement or
ion suppression in LC-MS analyses caused by matrix eﬀects, the
degradation of metabolites during sample preparation, and
unexpected variation in instrument responses. These factors all
result in the potentially biased quantiﬁcation of measured
metabolite concentrations.
True quantitative analyses can be achieved using synthesized
isotopic internal standards (IS) for a small number of
metabolites simultaneously.7 Isotope-dilution mass spectrome-
try (IDMS) is the most reliable technique for the generation of
accurate, MS-derived quantitative metabolite data because this
approach can correct for most aspects of analytical biases.8,9
Historically, the application of isotope dilution utilized
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radioactive tracers for the quantiﬁcation of a single or a small
set of analytes. Now, this has been replaced by the use of
nonradioactive stable isotopes.8 However, as the number of
metabolites monitored has increased in recent years, the
availability of matching isotopic standards for analytes has
become increasingly diﬃcult to achieve. Most isotopically
labeled compounds are diﬃcult to synthesize and are not
available commercially. The biosynthesis of multiple uniformly
13C-labeled (U-13C) IS for LC-IDMS is an alternative approach
that attempts to bypass the synthetic bottleneck by cultivating
organisms on 13C-labeled substrates as the sole carbon sources.
For example, Escherichia coli or yeast grown on 13C-glucose or
15N-labeled substrate sources, have been used to generate
labeled IS of metabolites for LC-IDMS in targeted metab-
olomics or metabolic-ﬂux analyses10−13 or for MS-method
improvements.14,15 However, the biosynthesis of multiple
U-13C IS is time-consuming and requires an expensive U-13C
carbon source, access to a microbiological laboratory, and the
associated skills. Commercially available U-13C spirulina
(Arthrospira platensis) has the potential to be used as a cheap
and readily accessible source of multiple U-13C IS suitable for
quantitative LC-IDMS of bacterial metabolites.
Clostridium autoethanogenum is a Gram-positive bacterial
species of biotechnological interest as it can ﬁx CO/CO2/H2 to
produce industrially useful chemicals, such as ethanol and 2,3-
butanediol.16−18 The yields of these chemicals are low in the
wild-type organism, and metabolic engineering and the
optimization of bioreactor conditions are required for eﬃcient
production. Speciﬁcally, our work required the generation of
accurate and quantitative measurements of key intracellular
metabolites of C. autoethanogenum to deliver important
information for computational metabolic modeling.
It is diﬃcult to biosynthesize U-13C-labeled internal stand-
ards in C. autoethanogenum because of the challenges with
growth on CO2 and CO as carbon sources. Therefore, in this
study, we evaluated a new method for LC-IDMS analysis using
purchasable U-13C-spirulina material as a novel source of
multiple IS for quantitative metabolomics. In previous studies,
15N- or 13C-labeled spirulina has mainly been used as a
feedstock for the stable-isotope labeling of mammals19−21 and
has not yet been explored for analytical applications. Spirulina is
supplied as a ready-to-use powder; thus, there is no need for
the cultivation of microorganisms to generate fully labeled IS.
The developed method was applied to the simultaneous
quantiﬁcation of 74 key intracellular metabolites in continuous
cultures of gas-fermentation extracts of C. autoethanogenum.
■ EXPERIMENTAL SECTION
Chemicals. HPLC-grade ammonium carbonate and all of
the analytical standards were purchased from Sigma-Aldrich
(Gillingham, U.K.) unless otherwise noted. Uniformly 13C-
labeled spirulina (U-13C, 97%) and 12C spirulina lyophilized-cell
powders were obtained from CK Isotopes (Ibstock, U.K.). MS-
grade acetonitrile and methanol were purchased from VWR
(Langenfeld, Germany). A set of 74 metabolites representing
the key intracellular metabolic pathways of C. autoethanogenum
was selected to monitor the intracellular metabolic changes.
Individual stock solutions of 100 mM 12C authentic standards
of these metabolites were used to prepare three diﬀerent 1 mM
standard mixtures in 50% (v/v) methanol/water.
LC-IDMS Analysis. LC-IDMS was performed using an
Accela or Dionex UHPLC system (Thermo Fisher Scientiﬁc,
Waltham, MA) coupled to a high-resolution orbital-trap mass
spectrometer (Exactive or Q-Exactive, Thermo Fisher Scien-
tiﬁc, Waltham, MA). A ZIC-pHILIC column (4.6 × 150 mm, 5
μm particle size, Merck Sequant, Watford, U.K.), maintained at
45 °C with a ﬂow rate of 300 μL/min, was used for the
chromatographic separation. Mobile phase A was composed of
20 mM ammonium carbonate in water (pH 9.1), and mobile
phase B was composed of acetonitrile. The gradient started
with 20% A and increased to 95% A over 8 min. This was
followed by equilibration to give a 15 min run time. The
injection volume was 5 μL, and samples were maintained at 4
°C during the analysis. MS was performed in simultaneous ESI
+ and ESI− full-scan modes with spray voltages of 4.5 (ESI+)
and 3.5 kV (ESI−) and capillary voltages of 40 (ESI+) and −30
V (ESI−). In both modes, the sheath-, auxiliary-, and sweep-gas
ﬂow rates were 40:5:1 arb unit, respectively, and the capillary
and heater temperatures were 275 and 150 °C, respectively.
Data were acquired with an automatic gain control of 1 × 106
and a resolution of 140 000 from m/z 70 to 1050.
Extraction and Characterization of U-13C-Labeled
Internal Standards (IS) from Spirulina. U-13C-labeled
intracellular metabolites were extracted from spirulina (0.5%,
w/v) with methanol (−20 °C), vortex-mixed for 30 s, stored
overnight at −20 °C, and centrifuged (10 000g, 5 min) to
remove the cell debris. The supernatant was ﬁltered through a 3
kDa cutoﬀ ﬁlter (Amicon Ultra, Merck, Watford, U.K.) and
spiked with 20 μM 2-ﬂuoro-2-deoxyuridine (ﬂuorinated-12C
IS). The spirulina extract was stored at −80 °C for use as
U-13C-labeled multiple IS for LC-IDMS. Untargeted analysis
was performed to check the coverage of metabolites in both
organisms. Extracts of spirulina and C. autoethanogenum and
blanks were prepared in biological triplicates and analyzed with
QC samples and 5 mixtures of 250 authentic standards in a
single analytical run. XCMS,22 mzMatch,23 and IDEOM
software24 were then used for untargeted data analysis, as
detailed by Kim et al.25 Metabolite identiﬁcation was carried
out by matching the accurate masses and RTs of the
chromatographic peaks with those of the authentic standards
(level 1 identiﬁcation) according to the metabolomics standards
initiative.26 Level 2 identiﬁcation was carried out for the rest of
the metabolites when standards were not available, and
therefore accurate masses and predicted RTs were used (see
Supporting Information Table S-1).
Validation and Quality Control of LC-IDMS for the
Quantiﬁcation of C. autoethanogenum Metabolites.
Calibration curves, validations, and metabolite quantiﬁcations
were generated using TraceFinder 3.1 software (Thermo Fisher
Scientiﬁc, Waltham, MA). Thirteen calibration standards in the
range of 1 nM to 200 μM were prepared in water from each
standard mixture and spiked with 1:1 (v/v) 0.5% spirulina
extracts (U-13C IS) and analyzed with LC-IDMS (n = 5). The
validity of the analytical method was assessed by measuring the
linearity, limit of detection (LOD), limit of quantiﬁcation
(LOQ), precision, accuracy, and repeatability of each standard
according to the FDA guidelines for bioanalysis.27 Signal-to-
noise ratios of 3:1 and 10:1 were used to estimate the LODs
and LOQs, respectively, whereas the correlation coeﬃcient
(R2) was used as a measure of linearity. The precision was
reported as the relative standard deviation (RSD) of the
standard response, and the accuracy was determined as the
percentage of the measured concentration of the analyte
compared with the true value. For the metabolite quantiﬁca-
tion, all of the calibration standards, the blank, and the
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extracted bioreactor-batch samples were analyzed in a single
analytical run with pooled QC samples interspaced every 10
samples. The concentrations of the metabolites of C.
autoethanogenum in the samples were determined using
standard calibration curves, and the obtained concentrations
were normalized to the corresponding sample ODs of the
bioreactor runs.
Strain and Culture Conditions of C. autoethanoge-
num. A C. autoethanogenum strain (DSM 10061) was
purchased from the Deutsche Sammlung von Mikroorganismen
und Zellkulturen GmbH culture collection (DSMZ, Braunsch-
weig, Germany). The bacteria were revived by growth on a
YTF agar medium, as stated elsewhere,28 in an anaerobic
cabinet (Don Whitley, West Yorkshire, U.K.) at 37 °C. The
CO-gas-shift experiment was conducted using 3 L water-
jacketed bioreactors in a continuous setup (BIOFLO 115, New
Brunswick Scientiﬁc, Edison, NJ). In each bioreactor, a C.
autoethanogenum seed culture was inoculated into a 1.5 L
aqueous culture medium (LanzaTech, Skokie, IL).29 Details of
the continuous CO-fed bioreactor cultivation of C. autoethano-
genum, the medium composition, and the bioreactor conditions
are given in the Supporting Information.
Sample Preparation for C. autoethanogenum Intra-
cellular Metabolite Determination. The bioreactor samples
of C. autoethanogenum were harvested when the OD measure-
ments at 600 nm (OD600) reached 3.95. Three samples (1 mL
each) of the cultures were collected every day throughout each
experiment (35 days); the samples were immediately cooled
down on ice to arrest metabolism and centrifuged at 10 000g
for 5 min at 4 °C. The supernatants were then removed
thoroughly, and the cell pellets were snap frozen in liquid
nitrogen and kept at −80 °C for the LC-IDMS analysis.
Four diﬀerent methods were evaluated for the extraction of
the polar and semipolar intracellular metabolites of C.
autoethanogenum: (1) solvent extraction (2:1:1 chloroform/
methanol/water), (2) freeze−thaw extraction, (3) homoge-
nization, and (4) sonication. For the ﬁrst two methods, the cell
pellets were resuspended in 150 μL of U-13C-IS extract and
vortexed for 30 s; then, 150 μL of water and 300 μL of
chloroform were added, and the solutions were kept overnight
at −20 °C (for the solvent extraction) or snap-frozen using
liquid nitrogen (for the freeze−thaw method). Then, samples
were centrifuged (10 000g, 5 min, 4 °C), and their aqueous
phases were analyzed with LC-MS. For the homogenization
method, 0.5 g of acid-washed glass beads (Sigma-Aldrich,
Gillingham, U.K.) were used to disrupt the cells using Precellys
homogenizer (Bertin Instruments, Montigny-le-Bretonneux,
France),30 and the supernatants were analyzed with LC-MS.
For the ﬁnal method, sonication, the cell pellets were
resuspended in 0.5 mL of deionized water, sonicated,
centrifuged, and analyzed.
Figure 1. Comparison of the identiﬁed metabolite classes from (a) spirulina and (b) C. autoethanogenum. In total, 267 and 279 metabolites were
tentatively identiﬁed using untargeted LC-MS proﬁling in the extracts of spirulina and C. autoethanogenum, respectively. (c) Metabolites common to
the two species according to metabolite class. The two species were found to have 211 metabolites in common.
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■ RESULTS AND DISCUSSION
Optimization of the LC-HRMS Method for the
Simultaneous Quantiﬁcation of C. autoethanogenum
Metabolites. The optimized ZIC-pHILIC LC-HRMS method
provided the quantitative analysis of a standard mixture of 74
metabolites of diﬀerent classes and structurally related
analogues simultaneously within a single 15 min analytical
run compared with a similar 45 min method reported by
others.31,32 In this optimized method, organic acids were eluted
at 4−9 min, amino acids were eluted at 8−12.5 min, and other
energy molecules and intermediates were eluted between 7 and
9.5 min. The method provided improved separation of organic
acids; isobaric compounds, such as dihydroxyacetone phos-
phate (DHAP) and glyceraldehyde-3-phosphate; and phos-
phorylated sugars (glucose 6-phosphate and fructose 6-
phosphate), making the method suitable for their quantiﬁcation
without the need for the longer HILIC LC-MS or MS/MS
analyses employed by others (see Supporting Information
Figure S-1).15,33,34 The main advantages of the developed
method are that it provides (1) rapid separation and conﬁrmed
identiﬁcation of many key intracellular metabolites in 15 min,
(2) improved annotation of metabolite peaks compared with
other LC-MS methods, and (3) the convenience of using
commercially available 13C spirulina over biosynthesized 13C IS.
Characterization and Extraction of Commercially
Available Spirulina as a Potential Source of IS for LC-
IDMS. 13C-Labeled lyophilized cell powder, obtained commer-
cially from spirulina grown on a 13C carbon source, was
investigated as a potential source of U-13C-labeled metabolites
for use as multiple U-13C IS for quantitative determination of
intracellular C. autoethanogenum metabolites using LC-IDMS.
The intracellular compositions of spirulina and C. autoethano-
genum were analyzed by LC-HRMS and compared to evaluate if
there was suﬃcient overlap in metabolites. Figure 1 shows that
a similar range and number of metabolites were tentatively
identiﬁed in both species. The full set of identiﬁed metabolites
in both species is listed in Supporting Information Table S-1.
The observed classes of metabolites were mainly related to
amino acid metabolism (38% in spirulina and 35% in C.
autoethanogenum), carbohydrate metabolism (11% in spirulina
and 10% in C. autoethanogenum), and nucleotide metabolism
(11% in spirulina and 12% in C. autoethanogenum). A total of
211 identiﬁed metabolites were cross-detected between the two
species; 187 (88.63%) of these metabolites were found 13C-
labeled in the extract of U-13C spirulina. Many of these are key
metabolites in amino acid, nucleotide, carbohydrate, TCA, and
energy metabolism pathways in C. autoethanogenum, conﬁrming
that the spirulina extract is an acceptable source of U-13C-
labeled IS for the LC-IDMS method described here. Others
have generated 13C-IS mixtures by growing organisms such as
E. coli or yeast on 13C6-glucose,
35−37 but these approaches are
more complex and expensive than the use of a commercial
source of 13C-labeled IS. We show that the number of identiﬁed
metabolites and metabolite classes in spirulina are similar to
those identiﬁed for E. coli13,25,38 and more than those reported
for Saccharomyces cerevisiae,10,39 the most common species used
to biosynthesize 13C IS for bacterial LC-IDMS. Thus, the use of
readily available 13C spirulina is a potential alternative to these
biogenerated approaches. Furthermore, the previous studies use
the same organisms for producing 13C-IS extracts for absolute
quantiﬁcation,10,38,40 but the LC-IDMS method developed here
can be easily transferred to various organisms that cannot be
grown on 13C-glucose as the sole carbon source.
The extraction of 13C metabolites from spirulina was
investigated using a range of concentrations of spirulina powder
(0.05−0.5%) with methanol and 2:1:1 chloroform/methanol/
water. Suﬃcient concentrations of the 13C metabolites were
extracted using 0.5% (or greater) spirulina powder in methanol
(Supporting Information Figure S-2). The stability and the
recovery of 13C-labeled key metabolites from U-13C spirulina
were also examined. Extracts of cell pellets of C. autoethano-
genum spiked with U-13C spirulina were kept at 4 °C for 36 h
and analyzed at diﬀerent time intervals with the optimized LC-
HRMS; 53 U-13C metabolites were detected and adequately
recovered (in the range of 80−120%), and 43 of those
metabolites were found to be stable (≥80%) with suitable
signal-to-noise ratios (≥10, i.e., ≥LOQ) for use as U-13C IS
(Supporting Information Figure S-3). Furthermore, their 13C-
isotopic purities in the pure extracts of U-13C spirulina (n = 13)
showed that there was minimal 12C present, with the majority
of the 13C metabolites having isotopic purities greater than 95%
(Supporting Information Figure S-4). This indicates a good
coverage of about 60% of the C. autoethanogenum metabolites
under investigation. The wide spectrum of metabolites
identiﬁed in the spirulina powder in this study shows the
potential of extending the use of labeled spirulina as a readily
available source of 13C IS for the absolute quantiﬁcation of C.
autoethanogenum metabolites and for potential applications
using LC-IDMS.
Optimization of the Bacterial-Sample Preparation for
the Extraction of Intracellular Metabolites. A set of eight
key intracellular metabolites of C. autoethanogenum was used to
optimize the extraction procedure. The extraction of the
metabolites via homogenization and freeze−thawing gave <60
Table 1. Selection of a suitable method for extracting the metabolites of C. autoethanogenum
extraction method (recovery %)
solvent extraction
metabolite freeze−thaw homogenization sonication 2:1:1a 1:2:2b 1:1c
fumarate 79 ± 9 57 ± 3 69 ± 0.39 99 ± 5 63 ± 8 77 ± 6
lactate 104 ± 0.02 101 ± 6 58 ± 11 69 ± 6
malate 51 ± 5 28 ± 2 98 ± 0.32 94 ± 4 70 ± 9 81 ± 9
citrate 43 ± 4 12 ± 7 88 ± 0.51 94 ± 4 80 ± 16 91 ± 5
glyoxylate    95 ± 19  
2-ketoisovalerate 31 ± 4 35 ± 0.2 53 ± 0.11  60 ± 2 74 ± 2
pyruvate 12 ± 4 8 ± 3 16 ± 0.26 107 ± 6 59 ± 12 80 ± 2
succinate   126 ± 0.22 103 ± 6 63 ± 3 78 ± 3
aChloroform/methanol/water. bAcetonitrile/methanol/water. cMethanol/water.
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and 80% recoveries, respectively, for all of the metabolites.
Extraction using sonication gave an 88% recovery for all of the
metabolites except for fumarate, 2-ketoisovalerate, and
pyruvate, for which lower recoveries of 69, 53, and 16%,
respectively, were observed. For the solvent extraction, the
proportion of solvents used was ﬁrst evaluated using diﬀerent
ranges of solvent combinations. The use of the chloroform/
methanol/water (2:1:1) extraction gave satisfactory results,
with 84% or higher recoveries for all of the metabolites (Table
1).
The use of cold-solvent extraction and sonication as
extraction methods gave better recoveries compared with the
use of homogenization and freeze−thawing, which was
consistent with other studies.41,42 However, lower recovery
percentages for some of the metabolites were observed with
sonication. This might reﬂect the increased oxidation processes
of these metabolites, which is consistent with observations
reported by Ohashi et al.43 For the solvent extraction, Lee et
al.44 recommended the use of methanol alone for the extraction
of intracellular metabolites of C. acetobutylicum for GC-MS, but
this solvent was found to be less suitable in our study. This
might be because most of the nonpolar metabolites were
retained in the chloroform layer, giving less interference and
cleaner chromatography of the polar metabolites in the aqueous
phase. This is supported by the successful use of chloroform in
varied proportions of chloroform/methanol/water, including
3:10:1,45 2.5:2.5:1,43 and 2:2:1.46 Hence, solvent extraction
with 2:1:1 chloroform/methanol/water was selected for
preparing the C. autoethanogenum samples for LC-IDMS.
Validation of LC-IDMS. The validation results of the LC-
IDMS method are summarized in Supporting Information
Table S-2. All of the responses of the metabolites were linear
over the working range of the calibration curves with R2 ≥ 0.99.
The precision and accuracy of the method at low (5 μM),
medium (10 μM), and high (50 μM) concentrations were
found to be within 15% RSD for 49 out of the 74 metabolites
and within 20% for all of the metabolites. The LODs and LOQs
of the pure standards were found to be within 1−500 nM and
1−1000 nM, respectively, for the majority of the metabolites
(66 out of 74) except for 2-hydroxyglutarate, glucose 6-
phosphate, glyceraldehyde-3-phosphate, lactate, L-serine, L-
tyrosine, L-valine, and NADH, for which higher LODs (1−5
Figure 2. Measured levels of C. autoethanogenum metabolites in low- and high-CO-fed bioreactor samples quantiﬁed using the developed LC-IDMS
method. The daily measured concentrations of metabolites (n = 3) were averaged at each steady state to provide a means of direct comparison
between the two bioreactor batches fed with low CO (blue bars) and high CO (orange bars) for 35 days. Insigniﬁcant diﬀerences in the measured
concentrations of the metabolites in the low- and the high-CO bioreactors (p-values ≤0.05) are indicated with dots (●), and the error bars (SD)
estimate both the analytical and biological variability within each bioreactor steady state. Diﬀerent scaling factors of metabolite concentrations have
been employed to improve the visual comparisons between the steady states of the two bioreactors: the top (white) has a scale of 1, middle (gray)
has a scale of 10, and the bottom (white) has a scale of 100.
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μM) and LOQs (5−10 μM) were observed. The performance
of the ZIC-pHILIC column was evaluated by monitoring the
RTs of the selected metabolites using a QC sample (n = 11)
interspaced within the analytical run of the extracted samples of
C. autoethanogenum (24−36 h). Adequate reproducibility was
observed in which the RTs of all of the metabolites were within
the range of RSDs of 0.07−0.94% (see Supporting Information
Table S-3). This result demonstrated that the multistep-
gradient optimization with a ﬂow-rate ramp from 300 to 400
μL/min not only improved the method throughput to 15 min
but also shortened the longer equilibration time usually
required with HILIC columns.31,32
The precision and accuracy of the quantitative measurements
of nucleotides and organic acids were found to be improved
compared with other similar 12C-LC-MS-based methods.47,48
The sensitivity achieved with the method is notably higher
when compared with previous methods reported for nucleo-
tides,13,49,50 amino acids,13,51 and organic acids13,51 using
similar methods. A full list of metabolites comparing the
method’s performance with those of similar reported studies is
available in Supporting Information Table S-3. Our results
indicate that the use of orbital-trap MS could achieve a
comparable or even higher sensitivity than that of the triple-
quadrupole-based detection for some metabolites without the
need to employ MS/MS.
Proﬁling of Intracellular Metabolites of C. autoetha-
nogenum to Optimize CO-Feed as a Sole Carbon Source.
The developed LC-IDMS method was then applied to monitor
the metabolic changes linked to the production of acetate,
ethanol, and 2,3-butanediol between two bioreactor batches fed
with CO as the sole carbon source at low- and high-ﬂow rates
(Supporting Information Figure S-5). LC-IDMS successfully
quantiﬁed 52 metabolites in C. autoethanogenum in the daily
samples analyzed over 35 days. A full list of metabolites and
their measured concentrations over time are available in
Supporting Information Table S-4. The measured levels of
metabolites were averaged at each steady state to provide a
means of direct comparison between the two bioreactors
(Figure 2). In the high-CO-fed bioreactor, low levels of
metabolites such as glycine, xanthine, ribose-5-phosphate,
sedoheptulose-7-phosphate, NADH, and AMP were observed
during both the acetogenic and solventogenic phases compared
with those in the low-CO-fed bioreactor, whereas lactate,
alanine, asparagine, tyrosine, acetyl CoA, acetyl phosphate, and
3-phosphoglycerate started to accumulate over time.
Mapping the selected set of metabolites to the main
pathways of C. autoethanogenum enhances our understanding
of the possible metabolic changes associated with high- and
low-CO-fed conditions (Figure 3). For instance, the increased
levels of acetyl CoA and acetyl phosphate in the high-CO-fed
bioreactor may signal an impaired production of ethanol by
aldehyde dehydrogenase (Ald), alcohol dehydrogenase (Adh),
or aldehyde oxidoreductase (Aor). Recently, Marcellin et al.
reported that Adh and Aor were up-regulated during CO
fermentation in C. autoethanogenum.52 It is believed that Aor
and Adh play an important role in the production of ethanol
from acetate53,54 and acetyl CoA52 in acetogens. This is
consistent with the results from the low-CO-fed bioreactor,
indicating that a high level of CO intake may down-regulate
these enzymes and hence produce a lower level of ethanol.
High CO ﬂow may aﬀect gluconeogenesis in C. autoethano-
genum. This is indicated by the absence of glyceradehyde-3-
Figure 3. Diﬀerent levels of intracellular metabolites mapped onto the main pathways of C. autoethanogenum involved in CO-gas fermentation. The
bar graphs represent the levels of metabolites during acetate−low-CO (gray bars), acetate−high-CO (red bars), ethanol−low-CO (blue bars),
ethanol−high-CO (green bars), and 2,3-butanediol−low-CO (orange bars) steady states.
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phosphate, DHAP, and fructose-6-phosphate, whereas in-
creased levels of 3-phosphoglycerate in all of the phases and
lactate in the solventogenic phase were found. In C.
autoethanogenum, pyruvate is converted to either lactate,
phosphoenolpyruvate (the precursor in the TCA cycle and
gluconeogenesis), or acetolactate.55 Therefore, these results
suggest that phosphoglycerate kinase and glyceraldehyde 3-
phosphate dehydrogenase, enzymes in gluconeogenesis (Figure
3), are downregulated in high CO ﬂows in favor of increased
production of lactate, which is consistent with other
studies.52,56
■ CONCLUSION
A new LC-IDMS method was successfully developed, validated
for the quantiﬁcation of bacterial metabolites, and applied to C.
autoethanogenum. The method demonstrated the potential of
using readily available labeled microorganisms as an easy route
of obtaining multiple U-13C IS. LC-IDMS, with the use of these
multiple IS, provides a powerful approach for the quantiﬁcation
of a range of key intracellular metabolites. We have successfully
analyzed more than 1300 samples with this method. Our
approach oﬀers improved quantitative pathway proﬁling for
systematic investigations of metabolic alterations and is suitable
for many applications requiring intra- and extracellular
metabolite proﬁling of microorganisms.
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